via Firstpost Tech Latest News https://ift.tt/2MGpWD9
COVAXIN shows interim efficacy of 81% against coronavirus in Phase 3 clinical trials, says Bharat Biotech
Related Posts
An average of five cryptojacking threats were seen every second in Q1 FY18: Report
Flextronics signs an MoU with Andhra Pradesh to manufacture smart products
Facebook is testing Keyword Snooze feature to hide spoilers from NewsFeed
Donald Trump to intensify security review to stop China from acquiring US technologies
Facebook's Instagram bet has paid off, but how long before child overtakes parent?
0 comments: